Eradikate Acne Mark Fading

Description

01b UC_EradiKate Acne Fading Gel is a topical formulation designed for the treatment of acne. The gel is specifically formulated to assist in the fading of post-acne marks and discoloration. It is presented in a gel dosage form, which facilitates easy application to affected areas. The product's composition includes active ingredients that target acne-related skin concerns, promoting a clearer complexion. The formulation is designed to be non-irritating and suitable for various skin types.

Uses and Indications

This drug is indicated for the treatment of acne. It helps keep the skin clear of new acne blemishes.

Dosage and Administration

The recommended dosage involves applying the product to targeted areas or the entire face, ensuring the skin is cleansed and dried prior to application. It is advised to avoid the eye area during application. The product should be allowed to fully absorb into the skin.

Initially, it is recommended to start with one application daily to minimize the risk of excessive skin drying. Based on individual tolerance and as directed by a healthcare professional, the frequency of application may be gradually increased to two or three times daily if necessary.

In cases where bothersome dryness or peeling occurs, it is advisable to reduce the frequency of application to once daily or every other day to maintain skin comfort and integrity.

Contraindications

Use is contraindicated in individuals who are unable to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a poison control center is advised.

Warnings and Precautions

FOR EXTERNAL USE ONLY. This product is intended solely for topical application.

When using this product, it is important to note that skin irritation or dryness may be exacerbated if another topical acne medication is used concurrently. To minimize the risk of irritation, it is recommended to use only one topical acne medication at a time.

In the event of accidental ingestion, immediate medical assistance should be sought. Contact a poison control center or seek emergency medical help without delay.

No additional specific precautions or laboratory tests have been identified for this product. Healthcare professionals are advised to monitor patients for any signs of adverse reactions and to provide guidance on the appropriate use of topical acne treatments.

Side Effects

Patients should be aware that this product is intended for external use only. When using this product, there is a risk of skin irritation or dryness, particularly if another topical acne medication is used concurrently. In such cases, if irritation occurs, it is advised to limit the use to one topical acne medication at a time to mitigate the risk of adverse reactions.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation or dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications should be considered to alleviate symptoms. Monitoring for signs of skin irritation is recommended when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Eradikate Acne Mark Fading (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or a poison control center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of ERADIKATE ACNE MARK FADING gel in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for any adverse effects is advisable in this population, given the lack of established guidelines for geriatric use.

Pregnancy

The safety of salicylic acid during pregnancy has not been established, and its use is contraindicated due to potential risks to the fetus. There is a known risk of teratogenic effects associated with the use of salicylic acid during pregnancy. Therefore, pregnant patients should avoid the use of this product unless directed by a healthcare provider. It is essential for women of childbearing potential to consult a healthcare professional before using this product if they are pregnant or planning to become pregnant.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and consider general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the clinical scenario and the substance involved. Consultation with a poison control center or a medical toxicologist may also be beneficial in managing the situation effectively.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for guiding treatment decisions and ensuring patient safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. Instruct patients that if the medication is swallowed, they should seek medical help immediately or contact a poison control center for assistance. It is important for patients to understand the urgency of this action to ensure their safety and the safety of others.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a cool, dry place to maintain its integrity and efficacy. Proper storage conditions are crucial to ensure the product remains effective throughout its shelf life.

Additional Clinical Information

The product is administered topically, with applications recommended in the morning and evening. Patients should apply it to targeted areas or over the entire cleansed and dried face, avoiding the eye area, and allow it to fully absorb into the skin. To minimize the risk of excessive skin drying, it is advised to start with one application daily, gradually increasing to two or three times daily as needed or directed by a clinician. If patients experience bothersome dryness or peeling, they should reduce the frequency of application to once a day or every other day.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Eradikate Acne Mark Fading, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)